Introduction
Increased proliferation has been shown to play an important role in asthma, a chronic inflammatory disease in which repeated cycles of damage and repair change the structure of the airways. These structural alterations, referred to as airway remodeling, is a process that includes increased smooth muscle mass [1] . Several cell types and inflammatory mediators have been suggested to contribute to airway remodeling. A growing amount of evidence support a role of platelets as important players in inflammatory airway diseases [2, 3] .
Platelets may play a role in that context, since they possess both inflammatory and proliferative properties. Platelets generate, express and release a variety of inflammatory mediators e.g. P-selectin and RANTES [4] [5] [6] . Furthermore, platelets express chemotactic and phagocytic receptors [7, 8] and are therefore able to undergo chemotaxis [9] and phagocytosis [10] . Studies have investigated the role of platelets in asthma and indicate that platelets from asthmatics express a different behaviour for example regarding aggregation response, cytosolic calcium mobilization and arachidonic acid metabolism [10, 11] . In addition, depletion of platelets in a murine model of chronic allergic inflammation markedly reduced airway remodeling [12] .
Leukotrienes are formed through the action of the enzyme 5-lipoxygenase (5-LOX) and are potent mediators of inflammation and allergic reactions [13] . A number of studies have also shown that 5-LOX metabolites influence on cell proliferation although the effects are celltype specific [14] [15] [16] [17] .
Reactive oxygen species (ROS) have recently been identified as important mediators of cell proliferation, differentiation [18] and adhesion [19, 20] . Exposure to low concentrations of hydrogen peroxide and/or superoxide anion stimulates growth of a variety of cell types, among them smooth muscle cells, fibroblasts, prostate cancer cells, and aortic endothelial cells [18, 21] . Ligand-receptor interactions induce production of ROS from several sources, including mitochondria, xanthine oxidase, and NADPH oxidase. NADPH/NADH oxidase activity are found in a variety of non-phagocytic cell types, such as smooth muscle cells, epithelial cells, endothelial cells, and platelets [18] .
Several studies have revealed interplay between ROS and eicosanoids in platelets, fibroblasts and smooth muscle cells from different species [22] [23] [24] . For example it has been shown that inhibition of 5-LOX blocks the rac-1-dependent ROS-generation [25] , furthermore a new report suggest that 5-LOX dependent ROS-generation is crucial for fibroblast adhesion [20] .
The aim of the present study was to evaluate a possible proliferative effect of platelets on airway smooth muscle cells (ASMC) in culture, and to assess the role of 5-LOX and ROS generation in this context. Increased knowledge of the mechanisms behind platelet-induced ASMC proliferation is important for understanding the mechanisms underlying airway remodeling and may provide new targets for treatment of inflammatory hyperproliferative disorders like asthma.
Methods

Chemicals
The chemicals used were as follows: Alexa Fluor 488 goat anti-mouse IgG, bodipy- 
Buffers and media
The following buffers and media were used in the experiments: phosphate-buffered saline pH sodium pyruvate, 1% non-essential amino acids, 100 U/ml penicillin, and 100 µg/ml streptomycin); complete medium (starvation medium with 10 % foetal bovine serum).
Cell culture
To exclude intra-human variations and host-donor reactions between platelets and ASMC we To achieve an optimal number of ASMC in the proliferation experiments 1,000-6,000 cells/well were seeded in 96-well microtiter plates, and they were subsequently incubated for 24 hours in a humidified atmosphere at 37°C and 5% CO 2 and analysed for cell growth with the MTS assay. Thereafter, we choose to use 3,000 cells per well, because that number enabled registration of both increases and decreases in proliferation (absorbance value: 0.57 ± 0.03, mean values ± S.E.M., n = 36).
ASMC in passages 7 to 20 were used in the following experiments.
Platelet preparation
Fresh blood from healthy donors was obtained from the blood bank at Linköping University Hospital, Linköping, Sweden. Only plastic utensils were used in the preparation procedure and all work was preformed at room temperature to avoid activation of the platelets. In short, five parts of the blood were mixed with one part of ACD solution and centrifuged for 20 minutes at 220 x g. The platelet-rich plasma obtained in the upper layer were removed and centrifuged for 20 minutes at 480 x g. The platelet pellet was gently washed and resuspended in KRG without calcium, and the platelets were counted in a Bürker chamber. The isolated platelets were disc shaped, unaggregated and functional. The functionality of the platelets was confirmed by measuring aggregation and mobilization of intracellular calcium [27] . Each preparation of platelets was microscopically examined and no contamination of other blood cells was observed.
ASMC proliferation
ASMC (3000/well) were seeded in medium containing 10% FBS, after 24 hours incubation growth was arrested by changing to starvation medium for 24 hours. Thereafter, cells were In a set of experiments platelets were treated with a mixture of platelet-inhibitors (ASA 100µM, apyrase 0.5 U/ml, PGE 1 and GEA 3175 1µM). Devices, Sunnyvale, CA) [28] . Proliferation was also analysed using the thymidine incorporation technique. Briefly, 2 μCi/ml [ 3 methyl-3 H]-thymidine was added to DMEM supplemented with 0.1 % FBS during the 24-hour incubation with the stimulus and the cells were subsequently washed twice with PBS pH 7.3 and then exposed to 5% ice-cold trichloroacetic acid (TCA) for 30 minutes. Next, liquid scintillation cocktail was added to the 96-wellplate and after 1 hour the amount of thymidine was determined using a scintillation counter (1450 Microbeta Trilux Wallac, Eg & G ® Lifescience, Turku, Finland). All drugs and solvents used were tested for interference with the assays. Proliferation was also measured by manual counting in a Bürker chamber and by measuring DNA using a NanoDrop ND-1000 UV-visible light spectrophotometer (Saveen Werner AB, Malmö, Sweden).
Reactive oxygen species
The intracellular redox state was registered using the fluorescent dye 2´,7´-dichlorodihydrofluoroscein diacetate (DCFDA) [29] . The ASMC were seeded and stimulated as described above (ASMC proliferation). Cells were incubated with the stimulus for 3 hours, and thereafter was 5 μM DCFDA added followed by 45 minutes incubation. The incubation time is based on the study by Berg et al. [30] . ROS production was evaluated by measuring the fluorescence in a FL-600 Microplate Flurorescence Reader (Bio-Tek instruments Inc, Winooski, VT). The excitation and emission filters were set at 485 ± 10 nm and 530 ± 12.5 nm, respectively.
Moreover, ROS was generated in a cell free suspension and the drugs were tested for scavenger effects. ROS generation; 0.02 U/ml xanthine oxidase and 0.03 mM hypoxanthine or 1.5 mM CuSO 4 and 0.3% H 2 O 2 . ROS was measured using horseradish peroxidase (HRP)-enhanced luminescence (4 U/ml HRP, 112 μM luminol).
Microscopic examination of the platelet-ASMC interaction
The interaction between ASMC and platelets was studied morphologically by fluorescent staining of the F-actin cytoskeleton in combination with fluorescence microscopy. ASMC were seeded on coverslips at a density of 10,000 cells/well. The seeded cells were incubated in complete medium for 24 hours in a humidified atmosphere at 37°C and 5% CO 2 .
Thereafter, the medium was changed to starvation medium and incubation was continued for approximately 24 hours. The ASMC were then incubated in DMEM supplemented with 0.1% FBS, in the absence (controls) or presence of platelets (ASMC/platelets ratio 1/1,000). After 3 and 24 hours, the samples were washed twice in PBS pH 7.3 and fixed for 30 minutes in 4%
paraformaldehyde at room temperature. The samples were subsequently permeabilized and stained in a mixture of lysophosphatidylcholine (100µg/ml) and bodipy-phallacidin (0.6µg/ml) in PBS pH 7.3. The coverslips were incubated for 30 minutes in dark at room temperature and then mounted in Dako fluorescent mounting medium on glass slides and put in the refrigerator prior fluorescence microscopy analysis (Carl Zeiss, Oberkochen, Germany).
Western blot analysis of 5-lipoxygenase
700,000 ASMC were seeded in petri dishes (ø 60 mm) in complete medium and incubated for 24 hours in a humidified atmosphere at 37 °C and 5% CO 2 . Growth was arrested using serumfree DMEM and after 24 hours of serum deprivation DMEM with 0.1% FBS was added and the cells were incubated for 2 hours at 37 °C and 5% CO 2 . Platelets were isolated as described above (platelet preparation). 
Statistical analysis
Results are expressed as mean values ± standard error of the mean (S.E.M). Student t-test was used to evaluate differences where the number of observations differed substantially between the groups to be compared, One-way ANOVA followed by Dunnet´s multiple comparison test was used in the remaining analyses. The statistical analyses performed are indicated in the figure legends. A p-value < 0.05 was considered to be significant, and significance is denoted * (p < 0.05), ** (p < 0.01) and *** (p < 0.001). Data were analysed using GraphPad Prism TM (GraphPad Software, San Diego, CA).
Results
Effects of platelets on ASMC proliferation
The MTS assay was used to study the effects of platelets on ASMC growth after 24 hours of co-incubation at an ASMC/platelet ratio of 1/100, 1/500, 1/1,000 or 1/2,000. The results show that the presence of platelets causes a marked dose-dependent increase in the proliferation of ASMC after only 24 hours (Figure 1 Experiments preformed in the presence of a mixture of platelet-inhibitors (the COX inhibitor ASA 100µM, apyrase 0.5 U/ml, the cAMP increasing drug PGE 1 and the NO donor GEA 3175 1µM) revealed that the drug treatment did not affect platelet-induced proliferation (176.6± 9.9 % and 176.9±12.3 % respectively, n=4).
Stimulation with platelet-derived growth factor-BB (PDGF-BB) (50 and 150 ng/ml) resulted in increased growth of ASMC with 142 ± 14.8 % (n = 3) and 154 ± 4.0 % (n = 9) compared to control, respectively.
Figure 1. Effects of platelets on ASMC proliferation. The MTS assay was used to analyse changes in ASMC growth after incubating the cells for 24 hours with different numbers of platelets. The thymidine incorporation technique (inset in A) was used to confirm the results when using human platelets (results from 9 separate cell passages and blood donors). The growth-inducing effect of both human (A) and guinea pig (B) platelets was ratio-dependent and equally potent. Data in experiments are expressed as means ± SEM and Student t-test was used for statistical analysis. Data obtained from 2-34 separate cell passages and blood donors at different ASMC/platelet ratios (1/100
, n = 6; 1/500, n = 4; 1/1,000, n = 34; 1/2,000, n = 2).
The interaction between platelets and ASMC was visualized by staining F-actin with bodipyphallacidin. Figure 2 shows that the platelets actually preferred to bind to the ASMC and not to the surface between the cells, and notably, a large number of platelets were still adhering to ASMC after 24 hours. We also performed morphological analyses based on staining of Factin with bodipy-phallacidin and immunoreaction with phycoerythrin conjugated anti-CD42b
antibodies to distinguish platelet structures from the ASMC (not shown). 
The role of eicosanoids in platelet-induced ASMC proliferation
Several studies have indicated that eicosanoids, especially 5-LOX metabolites, act as second messengers in cell proliferation [15, 31] . In the present study the Western blot analysis showed that the ASMC expressed 5-LOX, whereas the platelets did not (Figure 3) .
Figure 3. Expression of 5-LOX in ASMC and platelets. Western blot analyses showed that ASMC, but not platelets, expressed 5-LOX. Expression of 5-LOX was analysed using a primary mouse anti-5-LOX monoclonal IgG 1 antibody and a secondary horseradish peroxidase conjugated goat anti-mouse IgG antibody. Prior to Western blotting, the amount of DNA in each sample of ASMC was determined. The blot shown is representative of 8 independent experiments.
To ascertain whether the phospholipase A 2 (PLA 2 ) and the 5-LOX pathways are involved in platelet-mediated ASMC growth the PLA 2 inhibitor ATK and the 5-LOX inhibitor AA-861 was used. In the initial dose-response experiments, we exposed merely ASMC to AA-861 (0.1-100 μM) and ATK (0.1-100 μM) for 24 hours and analysed proliferation. The results revealed that the highest concentration used significantly reduced basal ASMC growth ( Figure 4A, 4B, insets) . Consequently, the concentrations utilized in the subsequent experiments had no significant impact on basal ASMC growth, but both ATK (10 μM) and AA-861 (0.1 and 10 μM) were found to significantly antagonise platelet-induced ASMC proliferation ( Figure 4A, 4B ).
Inasmuch as our results indicated that the 5-LOX pathway of arachidonic acid metabolism is essential for the ability of platelets to induce growth of ASMC, we examined whether some 5-LOX metabolites could mimic that effect. Neither LTC 4 nor LTB 4 (0.001, 0.01, 0.1, 1, 10 and 100 pM, n = 2-6) had a significant impact on ASMC proliferation. The lack of effect by LTB 4 was confirmed by our finding that platelet-induced ASMC proliferation was not influenced by Captopril ® (1, 5, 10 and 100 μM, n = 4), which inhibits the conversion of LTA 4 to LTB 4 . 
The role of reactive oxygen species in platelet-induced ASMC proliferation
Reactive oxygen species (ROS) have been identified as important mediators of cell proliferation [18] , and we found that production of these molecules, measured with the DCFDA, was increased in a ratio-dependent manner upon coincubation of ASMC with platelets ( Figure 5 ). However, stimulation with the platelet-derived mitogenic factor PDGF-BB (50 and 150 ng/ml) which resulted in significant ASMC proliferation, did not induce any increased ROS production measured with the DCFDA probe (data not shown). To elucidate the involvement of NADPH-oxidase in ROS generation and platelet-induced ASMC proliferation, the oxidase inhibitors DPI and apocynin were used. Platelet-induced proliferation was significantly reduced by DPI, as shown by both the thymidine incorporation assay ( Figure 6A ) and the MTS assay ( Figure 6A , inset), and according to both of those assays, the proliferation was also affected by apocynin ( Figure 6B ). The same concentrations of the two inhibitors had no significant impact on basal ASMC proliferation (data not shown).
To reveal a potential relationship between arachidonic acid metabolism and ROS generation, we measured the ROS-production generated upon coincubation of platelets and ASMC in the presence of the PLA 2 and 5-LOX inhibitors. We found that both AA-861 (0.1-10 μM; Figure   7A ) and ATK (0.1-10 μM; Figure 7B ) significantly inhibited the increased ROS-production.
The NADPH-oxidase-, PLA 2 -and 5-LOX-inhibitors did not influence on ROS-production measured in a cell free system (xantinoxidase-hypoxantine or CuSO 4 -H 2 O 2 model) (data not shown). 
Discussion
The interest in platelets as important players in inflammatory airway diseases has increased during recent years [2, 3] . Platelets may play a vital role in asthma through their possible impact on airway remodeling [12] where increased growth of ASMC is a main feature. In the present study, we demonstrate by using different cell proliferation assays (i.e. MTS-assay, DNA measurements and thymidine incorporation) that platelets dose-dependently increase ASMC proliferation. The pro-proliferative effect of platelets was powerful, taking into account that the measurements were performed after only 24 hours.
It has previously been suggested that ROS participate during cell adhesion and proliferation [19, 32] . We found that ROS generation was enhanced in a co-culture of platelets and ASMC.
Furthermore, inhibition of NADPH oxidase reduced the platelet-induced ASMC proliferation.
Hence, we suggest that platelets contribute to increased ROS generation which is accompanied by an elevated proliferation of ASMC.
In accordance with earlier studies [33, 34] , we showed that PDGF-BB caused ASMC proliferation. However, this effect was not associated with detectable ROS production. In addition, platelets, compared to high doses of external applied PDGF-BB, were more efficient in inducing ASMC proliferation. Furthermore, experiments preformed in the presence of a mixture of platelet-inhibitors revealed that the drug treatment did not affect platelet-induced proliferation, indicating that the proliferative capacity of platelets involves additional mechanisms besides release of alfa-granule-stored PDGF-BB.
Many studies in vitro have shown that arachidonic acid metabolites influence on cell proliferation although the effects are cell-type specific [14] [15] [16] [17] 35] . Cysteinyl leukotrienes, products of the 5-LOX pathway, have been implicated in various stages of airway inflammation, in the present study, we found that inhibition of PLA 2 and 5-LOX significantly reduced the ASMC proliferation caused by platelets. Western blot analysis also revealed that the ASMC, but not platelets, express 5-LOX. Consequently, we suggest that the 5-LOX pathway is important in ASMC proliferation induced by platelets. However, addition of the leukotrienes LTC 4 and LTB 4 to ASMC cultures did not elicit ASMC proliferation per se. In accordance, it was recently shown that cysteinyl leukotrienes alone did not induce proliferation, but acted in synergy with other factors [36] [37] [38] . Some studies indicate for a link between eicosanoids and ROS production [14, [22] [23] [24] . We found that inhibition of PLA 2 and 5-LOX antagonized both the ROS generation and the ASMC proliferation induced by platelets. This demonstrates that the 5-LOX pathway is coupled to increased ROS production also in a co-culture of platelets and ASMC, and that this is important for stimulating proliferation. Enzymes such as lipoxygenase and cyclooxygenase may directly generate superoxide anion via a side reaction that depends on the presence of reducing co-substrates [32] . However, our results strongly suggest that the NADPH oxidase is the enzymatic source for ROS production. Consequently, it is likely that activation of the 5-LOX pathway causes a NADPH-oxidase dependent ROS production in co-cultures of platelets and ASMC. The exact signalling cross-talk and specific 5-LOX product(s) that contributes to NADPH-oxidase mediated ROS generation remains to be determined.
Microscopic examination showed that platelets bind to the ASMC suggesting that platelet/ASMC adhesion is an important event in initiating proliferation. In accordance, some previous studies have shown that the proliferative properties of platelets or platelet-derived microparticles involve membrane structures and is not solely dependent on alfa-granulederived growth factors [39, 40] . The precise mechanisms underlying the binding between ASMC and platelets are however unknown.
From a clinical perspective, it has been shown that platelets in a symptomatic asthma group were found aggregated together with electron-dense fibrous material at the airway luminal edge [41] . Consequently, it is tempting to speculate that continuous recruitment and inappropriate activity of platelets in the airways may contribute to pathological situations and increased proliferation of ASMC.
In conclusion, our findings demonstrate a pronounced capacity of platelets in inducing ASMC proliferation. Based on the results, we propose that the 5-LOX pathway and the NADPHoxidase dependent ROS production are pivotal events in ASMC proliferation caused by platelets. This action of platelets represents a potential important and novel mechanism that may contributes to airway remodeling. The results may also have an impact in the development of new pharmacological strategies in the treatment of patients with inflammatory airway disorders.
